Key statistics
As of last trade, IMCD NV (IMDZF:PKL) traded at 155.95, 13.67% above the 52 week low of 137.20 set on Jul 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 154.79 |
---|---|
High | 155.95 |
Low | 154.79 |
Bid | -- |
Offer | -- |
Previous close | 155.95 |
Average volume | 120.00 |
---|---|
Shares outstanding | 59.11m |
Free float | 58.11m |
P/E (TTM) | 27.84 |
Market cap | 8.12bn EUR |
EPS (TTM) | 4.93 EUR |
Annual div (ADY) | 2.43 USD |
---|---|
Annual div yield (ADY) | 1.56% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of Nov 12 2024 17:09 GMT.
More ▼
Announcements
- IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares
- IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY
- IMCD reports EBITA of EUR 403 million in the first nine months of 2024
- IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- IMCD successfully issues a EUR 500 million rated bond
- IMCD reports EBITA of EUR 270 million in the first half of 2024
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
More ▼